Nasheed Hossain

1.7k total citations
24 papers, 272 citations indexed

About

Nasheed Hossain is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Nasheed Hossain has authored 24 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Nasheed Hossain's work include CAR-T cell therapy research (13 papers), Cancer Genomics and Diagnostics (5 papers) and Acute Myeloid Leukemia Research (3 papers). Nasheed Hossain is often cited by papers focused on CAR-T cell therapy research (13 papers), Cancer Genomics and Diagnostics (5 papers) and Acute Myeloid Leukemia Research (3 papers). Nasheed Hossain collaborates with scholars based in United States, Cameroon and Germany. Nasheed Hossain's co-authors include David B. Miklos, Jay Y. Spiegel, Matthew J. Frank, Saurabh Dahiya, Frederick L. Locke, Erin Dean, Katherine A. Kong, Ali Bukhari, Crystal L. Mackall and Aaron P. Rapoport and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nasheed Hossain

22 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasheed Hossain United States 8 176 81 64 61 57 24 272
Naomi Porret Switzerland 11 157 0.9× 48 0.6× 46 0.7× 130 2.1× 51 0.9× 41 440
Pierre Sesques France 10 259 1.5× 154 1.9× 46 0.7× 60 1.0× 18 0.3× 27 359
Elizabeth Budde United States 9 161 0.9× 63 0.8× 28 0.4× 105 1.7× 15 0.3× 26 275
Dana Průková Czechia 7 149 0.8× 103 1.3× 28 0.4× 139 2.3× 17 0.3× 14 296
Monalisa Ghosh United States 9 170 1.0× 46 0.6× 26 0.4× 87 1.4× 13 0.2× 45 308
Alessandro Crotta United States 7 273 1.6× 121 1.5× 43 0.7× 48 0.8× 7 0.1× 26 369
Nathan Denlinger United States 10 213 1.2× 55 0.7× 50 0.8× 76 1.2× 11 0.2× 31 336
Houli Zhao China 10 275 1.6× 38 0.5× 75 1.2× 100 1.6× 10 0.2× 24 338
Christine L. Phillips United States 11 247 1.4× 32 0.4× 66 1.0× 103 1.7× 13 0.2× 38 381

Countries citing papers authored by Nasheed Hossain

Since Specialization
Citations

This map shows the geographic impact of Nasheed Hossain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasheed Hossain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasheed Hossain more than expected).

Fields of papers citing papers by Nasheed Hossain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasheed Hossain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasheed Hossain. The network helps show where Nasheed Hossain may publish in the future.

Co-authorship network of co-authors of Nasheed Hossain

This figure shows the co-authorship network connecting the top 25 collaborators of Nasheed Hossain. A scholar is included among the top collaborators of Nasheed Hossain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasheed Hossain. Nasheed Hossain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ying, Yan Zhou, Mimi Chen, et al.. (2024). Enforced Expression of Mitochondrial Calcium Uniporter in Donor T Cells Abolishes Gvhd Progression. Blood. 144(Supplement 1). 3403–3403. 1 indexed citations
2.
Schneider, Michael, Elise A. Chong, Stefan K. Barta, et al.. (2024). Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2nd Line CAR T Therapy. Blood. 144(Supplement 1). 5123–5123.
3.
Dean, Erin, Matthew J. Frank, Nasheed Hossain, et al.. (2023). Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances. 7(16). 4608–4618. 16 indexed citations
4.
Hess, Brian, Nasheed Hossain, Volkan Beylergil, et al.. (2023). SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA. Hematological Oncology. 41(S2). 839–840. 3 indexed citations
5.
Mudaliar, Kumaran, et al.. (2022). Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia. SHILAP Revista de lepidopterología. 10(8). e6009–e6009. 2 indexed citations
6.
Nguyen, Amanda J., et al.. (2022). Transdifferentiation of high-grade B-cell lymphoma with MYC and BCL2 rearrangements into histiocytic sarcoma after CAR T-cell therapy: a case report. Journal of Hematopathology. 15(4). 229–237. 1 indexed citations
7.
Scurti, Gina, et al.. (2022). Genetic Modification of T Cells for the Immunotherapy of Cancer. Vaccines. 10(3). 457–457. 6 indexed citations
8.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2021). Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 39(27). 3034–3043. 87 indexed citations
10.
Hossain, Nasheed & Michael I. Nishimura. (2019). Late Events After CD-19 CAR-T Treatment. Biology of Blood and Marrow Transplantation. 26(1). e1–e2. 2 indexed citations
11.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2019). Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 884–884. 14 indexed citations
12.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2019). Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis.. Journal of Clinical Oncology. 37(15_suppl). 7552–7552. 6 indexed citations
13.
Hossain, Nasheed, Bita Sahaf, Jay Y. Spiegel, et al.. (2018). Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies. Blood. 132(Supplement 1). 490–490. 48 indexed citations
14.
Oak, Jean, Jay Y. Spiegel, Bita Sahaf, et al.. (2018). Target Antigen Downregulation and Other Mechanisms of Failure after Axicabtagene Ciloleucel (CAR19) Therapy. Blood. 132(Supplement 1). 4656–4656. 9 indexed citations
15.
Dahiya, Saurabh, et al.. (2017). Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR-T therapy.. Journal of Clinical Oncology. 35(15_suppl). 7552–7552. 2 indexed citations
16.
Hossain, Nasheed, Aude G. Chapuis, & Roland B. Walter. (2016). T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies. Current Hematologic Malignancy Reports. 11(4). 311–317. 7 indexed citations
17.
Hossain, Nasheed, Thomas R. Klumpp, Patricia Kropf, et al.. (2015). Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?. Clinical Lymphoma Myeloma & Leukemia. 16(2). 111–115. 6 indexed citations
18.
Hossain, Nasheed, et al.. (2012). A 32-Year-Old Man With Persistent Cough, Shortness of Breath, Eosinophilic Pneumonia, and Peripheral Blood Eosinophilia. CHEST Journal. 142(6). 1680–1683. 4 indexed citations
19.
Ndom, Paul, et al.. (2012). A meta-analysis of male breast cancer in Africa. The Breast. 21(3). 237–241. 30 indexed citations
20.
Reineke, Lucas C., Yu Cao, Diane Baus, Nasheed Hossain, & William C. Merrick. (2011). Insights into the Role of Yeast eIF2A in IRES-Mediated Translation. PLoS ONE. 6(9). e24492–e24492. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026